CYP2C9 and hepatocellular carcinoma: Because of the low expression of DMEs and transporters by HepaG2 and other hepatocellular carcinoma cell lines30, 42, we used HepaRG cells, which express DMEs and transporters at levels similar to primary hepatocytes, to investigate the suppression effects of hsa-miR-128-3p on endogenous CYP2C9 expression and translation.